EP4230050A1 - Method for preparing milk oligosaccharide, oligosaccharide powder prepared using same, and food - Google Patents
Method for preparing milk oligosaccharide, oligosaccharide powder prepared using same, and food Download PDFInfo
- Publication number
- EP4230050A1 EP4230050A1 EP22859565.8A EP22859565A EP4230050A1 EP 4230050 A1 EP4230050 A1 EP 4230050A1 EP 22859565 A EP22859565 A EP 22859565A EP 4230050 A1 EP4230050 A1 EP 4230050A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- nanofiltration
- optionally
- ultrafiltration
- microfiltration
- retentate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001542 oligosaccharide Polymers 0.000 title claims abstract description 125
- 150000002482 oligosaccharides Chemical class 0.000 title claims abstract description 125
- 235000013336 milk Nutrition 0.000 title claims abstract description 87
- 239000008267 milk Substances 0.000 title claims abstract description 87
- 210000004080 milk Anatomy 0.000 title claims abstract description 87
- 238000000034 method Methods 0.000 title claims abstract description 63
- 239000000843 powder Substances 0.000 title claims abstract description 56
- 235000013305 food Nutrition 0.000 title claims abstract description 14
- 238000001728 nano-filtration Methods 0.000 claims abstract description 138
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 94
- 239000012466 permeate Substances 0.000 claims abstract description 78
- 239000012465 retentate Substances 0.000 claims abstract description 78
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 53
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 53
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 47
- 239000005862 Whey Substances 0.000 claims abstract description 47
- 239000008101 lactose Substances 0.000 claims abstract description 46
- 239000007788 liquid Substances 0.000 claims abstract description 43
- 241000283690 Bos taurus Species 0.000 claims abstract description 42
- 238000010612 desalination reaction Methods 0.000 claims abstract description 33
- OIZGSVFYNBZVIK-FHHHURIISA-N 3'-sialyllactose Chemical compound O1[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(=O)C)[C@@H](O)C[C@@]1(C(O)=O)O[C@@H]1[C@@H](O)[C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]1O OIZGSVFYNBZVIK-FHHHURIISA-N 0.000 claims abstract description 21
- 238000013375 chromatographic separation Methods 0.000 claims abstract description 17
- 238000001035 drying Methods 0.000 claims abstract description 11
- TYALNJQZQRNQNQ-UHFFFAOYSA-N #alpha;2,6-sialyllactose Natural products O1C(C(O)C(O)CO)C(NC(=O)C)C(O)CC1(C(O)=O)OCC1C(O)C(O)C(O)C(OC2C(C(O)C(O)OC2CO)O)O1 TYALNJQZQRNQNQ-UHFFFAOYSA-N 0.000 claims abstract description 10
- CILYIEBUXJIHCO-UHFFFAOYSA-N 102778-91-6 Natural products O1C(C(O)C(O)CO)C(NC(=O)C)C(O)CC1(C(O)=O)OC1C(O)C(OC2C(C(O)C(O)OC2CO)O)OC(CO)C1O CILYIEBUXJIHCO-UHFFFAOYSA-N 0.000 claims abstract description 10
- DVGKRPYUFRZAQW-UHFFFAOYSA-N 3 prime Natural products CC(=O)NC1OC(CC(O)C1C(O)C(O)CO)(OC2C(O)C(CO)OC(OC3C(O)C(O)C(O)OC3CO)C2O)C(=O)O DVGKRPYUFRZAQW-UHFFFAOYSA-N 0.000 claims abstract description 10
- CILYIEBUXJIHCO-UITFWXMXSA-N N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose Chemical compound O1[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(=O)C)[C@@H](O)C[C@@]1(C(O)=O)O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)O[C@@H]2CO)O)O[C@H](CO)[C@@H]1O CILYIEBUXJIHCO-UITFWXMXSA-N 0.000 claims abstract description 10
- OIZGSVFYNBZVIK-UHFFFAOYSA-N N-acetylneuraminosyl-D-lactose Natural products O1C(C(O)C(O)CO)C(NC(=O)C)C(O)CC1(C(O)=O)OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1O OIZGSVFYNBZVIK-UHFFFAOYSA-N 0.000 claims abstract description 10
- TYALNJQZQRNQNQ-JLYOMPFMSA-N alpha-Neup5Ac-(2->6)-beta-D-Galp-(1->4)-beta-D-Glcp Chemical compound O1[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(=O)C)[C@@H](O)C[C@@]1(C(O)=O)OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)O[C@@H]2CO)O)O1 TYALNJQZQRNQNQ-JLYOMPFMSA-N 0.000 claims abstract description 10
- 238000011097 chromatography purification Methods 0.000 claims abstract description 8
- 238000001471 micro-filtration Methods 0.000 claims description 89
- 239000012528 membrane Substances 0.000 claims description 64
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 56
- 238000001514 detection method Methods 0.000 claims description 39
- 238000001223 reverse osmosis Methods 0.000 claims description 33
- 239000008367 deionised water Substances 0.000 claims description 23
- 229910021641 deionized water Inorganic materials 0.000 claims description 23
- 235000020244 animal milk Nutrition 0.000 claims description 20
- 238000007865 diluting Methods 0.000 claims description 18
- 238000000909 electrodialysis Methods 0.000 claims description 14
- 238000011068 loading method Methods 0.000 claims description 14
- 238000004108 freeze drying Methods 0.000 claims description 13
- 238000000502 dialysis Methods 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- 239000012564 Q sepharose fast flow resin Substances 0.000 claims description 8
- 239000002131 composite material Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 229920002271 DEAE-Sepharose Polymers 0.000 claims description 7
- 239000012505 Superdex™ Substances 0.000 claims description 7
- 238000012856 packing Methods 0.000 claims description 7
- 235000020185 raw untreated milk Nutrition 0.000 claims description 7
- 239000006227 byproduct Substances 0.000 claims description 6
- 238000010790 dilution Methods 0.000 claims description 6
- 239000012895 dilution Substances 0.000 claims description 6
- 239000000919 ceramic Substances 0.000 claims description 5
- 235000013351 cheese Nutrition 0.000 claims description 5
- 230000036541 health Effects 0.000 claims description 5
- 239000011148 porous material Substances 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 5
- 229920000936 Agarose Polymers 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 230000001351 cycling effect Effects 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 230000033228 biological regulation Effects 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 3
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 3
- 239000012498 ultrapure water Substances 0.000 claims description 3
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 229920002307 Dextran Polymers 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 6
- 235000013365 dairy product Nutrition 0.000 abstract description 5
- 239000000796 flavoring agent Substances 0.000 abstract description 5
- 235000019634 flavors Nutrition 0.000 abstract description 5
- 238000012545 processing Methods 0.000 abstract description 5
- 239000000243 solution Substances 0.000 description 41
- 238000000926 separation method Methods 0.000 description 32
- 210000004379 membrane Anatomy 0.000 description 25
- 238000004587 chromatography analysis Methods 0.000 description 22
- 230000000052 comparative effect Effects 0.000 description 21
- 229920002684 Sepharose Polymers 0.000 description 20
- 235000020256 human milk Nutrition 0.000 description 17
- 210000004251 human milk Anatomy 0.000 description 17
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 16
- 238000000746 purification Methods 0.000 description 12
- 238000005516 engineering process Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- PXBFMLJZNCDSMP-UHFFFAOYSA-N 2-Aminobenzamide Chemical compound NC(=O)C1=CC=CC=C1N PXBFMLJZNCDSMP-UHFFFAOYSA-N 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 235000013406 prebiotics Nutrition 0.000 description 7
- 235000020183 skimmed milk Nutrition 0.000 description 7
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 102000011632 Caseins Human genes 0.000 description 6
- 108010076119 Caseins Proteins 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 235000021119 whey protein Nutrition 0.000 description 6
- 235000013350 formula milk Nutrition 0.000 description 5
- 239000000178 monomer Substances 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 4
- QHXLIQMGIGEHJP-UHFFFAOYSA-N boron;2-methylpyridine Chemical compound [B].CC1=CC=CC=N1 QHXLIQMGIGEHJP-UHFFFAOYSA-N 0.000 description 4
- 239000005018 casein Substances 0.000 description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 4
- 235000021240 caseins Nutrition 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000013078 crystal Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- -1 glycan BEH Amide Chemical class 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000009928 pasteurization Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 2
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 2
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000009795 derivation Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 2
- 150000003271 galactooligosaccharides Chemical class 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 229950006780 n-acetylglucosamine Drugs 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000006268 reductive amination reaction Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- PNIWLNAGKUGXDO-LNCRCTFVSA-N (2s,3r,4s,5r,6r)-2-[(2r,3s,4r,5r)-5-amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical group O[C@@H]1[C@@H](N)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 PNIWLNAGKUGXDO-LNCRCTFVSA-N 0.000 description 1
- 229940062827 2'-fucosyllactose Drugs 0.000 description 1
- HWHQUWQCBPAQQH-UHFFFAOYSA-N 2-O-alpha-L-Fucosyl-lactose Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC(C(O)CO)C(O)C(O)C=O HWHQUWQCBPAQQH-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102000006471 Fucosyltransferases Human genes 0.000 description 1
- 108010019236 Fucosyltransferases Proteins 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- LKOHREGGXUJGKC-UHFFFAOYSA-N Lactodifucotetraose Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)OC2CO)OC2C(C(O)C(O)C(C)O2)O)OC(CO)C(O)C1O LKOHREGGXUJGKC-UHFFFAOYSA-N 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 description 1
- 206010051606 Necrotising colitis Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- SNFSYLYCDAVZGP-UHFFFAOYSA-N UNPD26986 Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(O)C(O)C2O)CO)OC(CO)C(O)C1O SNFSYLYCDAVZGP-UHFFFAOYSA-N 0.000 description 1
- YVNQAIFQFWTPLQ-UHFFFAOYSA-O [4-[[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylidene]-3-methylcyclohexa-2,5-dien-1-ylidene]-ethyl-[(3-sulfophenyl)methyl]azanium Chemical compound C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=C1 YVNQAIFQFWTPLQ-UHFFFAOYSA-O 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001994 activation Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- PHTAQVMXYWFMHF-GJGMMKECSA-N alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-D-GlcpNAc Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H](OC(O)[C@H](NC(C)=O)[C@H]2O)CO)O[C@H](CO)[C@H](O)[C@@H]1O PHTAQVMXYWFMHF-GJGMMKECSA-N 0.000 description 1
- LKOHREGGXUJGKC-GXSKDVPZSA-N alpha-L-Fucp-(1->3)-[alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)]-beta-D-Glcp Chemical compound C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]2O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)[C@@H](O)[C@H](O)[C@@H]1O LKOHREGGXUJGKC-GXSKDVPZSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000011544 gradient gel Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 150000002597 lactoses Chemical class 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 208000004995 necrotizing enterocolitis Diseases 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 201000006195 perinatal necrotizing enterocolitis Diseases 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 235000021249 α-casein Nutrition 0.000 description 1
- 235000021241 α-lactalbumin Nutrition 0.000 description 1
- 235000021247 β-casein Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/144—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by electrical means, e.g. electrodialysis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/146—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by ion-exchange
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/146—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by ion-exchange
- A23C9/1465—Chromatographic separation of protein or lactose fraction; Adsorption of protein or lactose fraction followed by elution
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/40—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by drying or kilning; Subsequent reconstitution
- A23L3/44—Freeze-drying
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/20—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the sorbent material
- B01D15/206—Packing or coating
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/02—Reverse osmosis; Hyperfiltration ; Nanofiltration
- B01D61/025—Reverse osmosis; Hyperfiltration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/02—Reverse osmosis; Hyperfiltration ; Nanofiltration
- B01D61/027—Nanofiltration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/02—Reverse osmosis; Hyperfiltration ; Nanofiltration
- B01D61/027—Nanofiltration
- B01D61/0271—Nanofiltration comprising multiple nanofiltration steps
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/02—Reverse osmosis; Hyperfiltration ; Nanofiltration
- B01D61/029—Multistep processes comprising different kinds of membrane processes selected from reverse osmosis, hyperfiltration or nanofiltration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/145—Ultrafiltration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/145—Ultrafiltration
- B01D61/146—Ultrafiltration comprising multiple ultrafiltration steps
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/147—Microfiltration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/147—Microfiltration
- B01D61/1471—Microfiltration comprising multiple microfiltration steps
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/149—Multistep processes comprising different kinds of membrane processes selected from ultrafiltration or microfiltration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/42—Electrodialysis; Electro-osmosis ; Electro-ultrafiltration; Membrane capacitive deionization
- B01D61/422—Electrodialysis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/58—Multistep processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/02—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor characterised by their properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/04—Tubular membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/02—Inorganic material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
- C07H1/08—Separation; Purification from natural products
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/04—Disaccharides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/24—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the treatment of the fractions to be distributed
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/34—Size selective separation, e.g. size exclusion chromatography, gel filtration, permeation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/06—Specific process operations in the permeate stream
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/08—Specific process operations in the concentrate stream
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/10—Temperature control
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/25—Recirculation, recycling or bypass, e.g. recirculation of concentrate into the feed
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/26—Further operations combined with membrane separation processes
- B01D2311/2697—Chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/26—Further operations combined with membrane separation processes
- B01D2311/2699—Drying
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/02—Details relating to pores or porosity of the membranes
- B01D2325/0283—Pore size
- B01D2325/02833—Pore size more than 10 and up to 100 nm
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/02—Details relating to pores or porosity of the membranes
- B01D2325/0283—Pore size
- B01D2325/02834—Pore size more than 0.1 and up to 1 µm
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/20—Specific permeability or cut-off range
Definitions
- the present application relates to the technical field of further processing of dairy products, and in particular to a preparation method of milk oligosaccharides, and oligosaccharide powder and food prepared thereby.
- HMOs Human milk oligosaccharides
- HMO Human milk oligosaccharides are of great structural diversity. There are great variations in both concentration and composition between individuals and during lactation period. They appear as free structures or combine with macromolecules such as glycoproteins and glycolipids.
- the structure of HMO mainly consists of five monomers: glucose, galactose, N -acetylglucosamine, fucose and N -acetyl neuraminic acid, each HMO comprising a lactose residue as its core, which can be elongated by repeated lactosamine units to form a straight or branched chain structure.
- the formed linear or branched chain structure can be further elongated in the presence of fucosyl transferase and sialic acid transferase to form a fucosylated and sialylated oligosaccharide.
- HMOs HMOs, initially discovered as a "bifidus factor", can be used as a metabolic substrate for desired bacteria and contribute to the formation of dominant intestinal flora.
- HMOs also play a role in anti-adhesion, anti-bacteria, regulation of intestinal epithelium and immune cells, reduction of excessive mucosal leukocyte infiltration and activation, reduction of neonatal necrotizing enterocolitis, and provision of sialic acid as a potential necessary nutrient for brain development and cognition of infants. Therefore, the World Health Organization recommends that infants are exclusively breastfed for the first 6 months after birth.
- membrane separation technology has developed rapidly and has been widely used in various industries due to the advantages of energy saving, consumption reduction, no phase change, and no pollution, and has been widely used in dairy industry, such as microfiltration sterilization, skim milk separation, whey separation, lactose concentration, reverse osmosis to remove water, etc., which shows incomparable advantages over traditional methods, and can realize the real recycling of by-products.
- dairy industry such as microfiltration sterilization, skim milk separation, whey separation, lactose concentration, reverse osmosis to remove water, etc.
- the application of membrane technology to sterilization of milk and separation of milk components such as whey protein, casein, ⁇ -lactalbumin, ⁇ -lactoglobulin, ⁇ -casein, and ⁇ -casein has become a hot topic at home and abroad.
- Membrane separation technology is an environmentally friendly physical separation process, consumes less energy, compared with rotary, single-effect or multi-effect evaporation, freeze-drying, or spray drying, and does not need to add any toxic and harmful organic reagents in the separation process.
- the operation temperature is low, which is especially suitable for heat-sensitive components, and will not destroy the natural structures of proteins, lactoses, and oligosaccharides, thus producing products with better functional characteristics. It shows more application value and a great practical prospect in dairy processing.
- Bovine whey is a by-product produced in cheese manufacturing or a natural permeate prepared by microfiltration, which is usually discharged as waste liquid or prepared by spray drying into whey powder for sale at low prices. Compared with other livestock milk, it has the advantages of large quantity and low cost. Therefore, it is of great significance to extract bovine milk oligosaccharides from whey (including sweet whey, reconstituted desalted whey, microfiltration permeate of milk, etc.) on a large scale for use as a substitute for human milk oligosaccharides. At present, no substitute for human milk oligosaccharide has been obtained from milk of any animal origin to meet the commercial demand.
- the present disclosure provides a method for preparing milk oligosaccharides, and oligosaccharide powder and food prepared by the method.
- Animal milk oligosaccharides are new ingredients imitating human milk oligosaccharides, and are similar to human milk oligosaccharides in structure and biological function. Therefore, by applying bovine milk oligosaccharides in replacement of galactooligosaccharide and fructooligosaccharide in functional foods such as infant formula and special medicine, it can not only produce health value, but also has the opportunity to obtain higher additive values in dairy products that are not fully utilized at present.
- the present disclosure provides technical solutions as follows:
- a method for preparing milk oligosaccharides which comprises the following steps: performing ultrafiltration of whey liquid for at least three times, subjecting the ultrafiltration permeate to nanofiltration concentration for several times, then subjecting the nanofiltration retentate to chromatographic separation and purification, collecting chromatographic collection liquid containing sialyllactose while removing the fraction containing lactose, subjecting the collection to desalination and drying to obtain oligosaccharide powder.
- the procedure of collecting chromatographic collection liquid containing sialyllactose comprises: collecting chromatographic collection liquid into a tube and performing detections on the same, and combining the chromatographic collection liquid containing sialyllactose, in which the detection of sialyllactose is performed by the oligosaccharide detection method.
- the drying procedure is performed by freeze drying; optionally, the freeze-drying step comprises: loading the desalted concentrated retentate into a freeze dryer for drying; further optionally, the freeze-drying step comprises: setting the heating program of the vacuum freeze-drying as: 20°C for 2 h, 40°C for 1 h, and 55°C until to the end, with the cold trap temperature being set at -50°C, and the vacuum degree at 2.50 to 6.50 MPa; and the drying procedure is not finished until the moisture content on dry basis is less than 5%.
- the chromatographic packing material uses a cross-linked complex of agarose and dextran or a cross-linked agarose as the carrier; optionally, the carrier of the chromatographic packing material is Superdex 30 increase pre-loaded column, or DEAE-Sepharose Fast Flow, or Q-Sepharose Fast Flow; optionally, the procedure of chromatographic separation and purification comprises:
- the chromatographic packing material used in the present disclosure has the advantages of heat resistance, pressure resistance, high resolution, high chemical stability, high flow rate, high load, ease to in-situ cleaning, reusability, low nonspecific adsorption, and high recovery rate, and is suitable for industrial scale production.
- the whey liquid is a by-product whey liquid produced during cheese manufacturing, or a whey liquid after the desalted whey powder is reconstituted, or a permeate prepared by microfiltration of skimmed animal milk, in which, optionally, the animal milk is bovine milk; and
- the microfiltration is performed under conditions as follows: the feed temperature is 45 °C to 55 °C, the inlet pressure is 2 to 5 bar, the outlet pressure is 1 to 4 bar, the back pressure is 0.5 to 3 bar, and the membrane pressure difference is less than 3 bar. It is noted that if the pressure is too high, the membrane will be blocked seriously, and the concentration polarization will be accelerated, which will affect the permeability of bovine milk oligosaccharides. In addition, too large or too small membrane pressure difference will lead to low separation efficiency, time-consuming and energy-consuming, and susceptibility to microbial contamination.
- the purpose of multiple microfiltrations of skimmed animal milk is to remove casein from the skimmed milk, so as to prevent contamination of the ultrafiltration membrane in the next stage, while separating more milk oligosaccharides.
- the ultrafiltration for at least three times comprises: concentrating the microfiltration permeate through ultrafiltration until reaching 2 to 7 cycles of concentration to obtain the first ultrafiltration permeate; diluting the first ultrafiltration retentate with water, followed by concentrating through ultrafiltration until reaching 2 to 7 cycles of concentration to obtain the second ultrafiltration permeate; diluting the second ultrafiltration retentate with water, followed by concentrating through ultrafiltration until reaching 2 to 7 cycles of concentration to obtain the third ultrafiltration permeate, and so on; optionally, the ultrafiltration is performed six times; optionally, the amount of water added for dilution is similar to the mass of ultrafiltration retentate to be diluted.
- the used ultrafiltration membrane has a molecular weight cut-off of 5 kDa to 30 kDa; optionally, the ultrafiltration membrane is a composite tubular organic membrane.
- Organic membranes have the advantages of large effective membrane area, low price, low investment, uniform pore size distribution, and ease to operation and cleaning.
- the ultrafiltration is performed under conditions as follows: the feed temperature is 20 °C to 45 °C, the inlet pressure is 6 to 9 bar, the outlet pressure is 5 to 8 bar; optionally, the membrane pressure difference is not more than 3 bar.
- the procedure of nanofiltration concentration for several times comprises: concentrating the ultrafiltration permeate through nanofiltration until reaching 2 to 13 cycles of concentration to obtain the first nanofiltration retentate; diluting the first nanofiltration retentate with water, followed by concentrating through nanofiltration until reaching 2 to 13 cycles of concentration to obtain the second nanofiltration retentate; diluting the second nanofiltration retentate with water, followed by concentrating through nanofiltration until reaching 2 to 13 cycles of concentration to obtain the third nanofiltration retentate, and so on; alternatively, the nanofiltration is performed six times; optionally, the amount of water added for dilution is similar to that of nanofiltration retentate to be diluted.
- the used nanofiltration membrane has a molecular weight cut-off of 100 Da to 3000 Da; optionally, the nanofiltration membrane used in the nanofiltration step is a composite tubular organic membrane.
- the nanofiltration is performed under conditions as follows: the feed temperature is 20 °C to 45 °C, the inlet pressure is 16 to 20 bar, the outlet pressure is 14 to 18 bar; optionally, the membrane pressure difference is not more than 3 bar.
- the desalination is performed by nanofiltration or electrodialysis
- the method of the present application further comprises: concentrating the nanofiltration permeate by reverse osmosis to generate deionized water suitable for the process;
- the invention provides an oligosaccharide powder, which is a milk oligosaccharide powder prepared by the present method; optionally, the milk oligosaccharide powder comprises sialyllactose; optionally, the sialyllactose comprises 3'-sialyllactose and 6'-sialyllactose; optionally, the total percentage content of 3'-sialyllactose and 6'-sialyllactose in the milk oligosaccharide powder is not less than 25% by mass.
- the invention provides an oligosaccharide food or health product, which comprises the oligosaccharide powder prepared by the present method or the oligosaccharide powder as described above.
- the oligosaccharide food or health product comprises an oligosaccharide powder prepared by the present method; optionally, the oligosaccharide powder comprises sialyllactose, which optionally comprises 3'-sialyllactose and 6'-sialyllactose.
- lactose there is no cross relationship between the separately mentioned term “lactose” and the term “sialyllactose” in the present disclosure.
- lactose in the present disclosure refers to 1,4-galactoside glucose, while the term “sialyllactose” belongs to prebiotic oligosaccharides.
- the oligosaccharides separated from whey liquid in the present application mainly comprise sialyllactose.
- the present disclosure provides a method for preparing milk oligosaccharides by using whey liquid as raw material, which can be originated from the following three sources: 1) whey liquid as a by-product produced during cheese manufacturing; 2) whey liquid obtained after reconstitution of desalted whey powder; 3) the permeate prepared by microfiltration of the skimmed animal milk (usually bovine milk);
- whey liquid as a by-product produced during cheese manufacturing, or whey liquid obtained after reconstitution of desalted whey powder can be subjected to ultrafiltration directly or after a simple filtration; generally, the whey liquid obtained after reconstitution of desalted whey powder is prepared by using desalted whey powder and water at the mass ratio of 1: 4 to 20.
- lactose and bovine milk oligosaccharides are detected as follows:
- the method for detecting bovine milk oligosaccharides is as follows: diluting skimmed milk by 100 times, diluting the permeate by 2 times, after passing through 0.22 ⁇ m nylon filter membrane, taking 100 ⁇ L of stock solution or 100 ⁇ L of the separated oligosaccharide sample, to which 50 ⁇ L of a 0.5 M solution of 2-aminobenzamide (serving as a derivative reagent) and a 1 M solution of 2-methylpyridine borane complex (serving as a reductive amination reagent for labelling saccharides) are added respectively, after mixing evenly, carrying out derivation at 65 °C for 2.5 h, then cooling to room temperature, and loading the same into a liquid vial for detection, wherein both the solution of 2-aminobenzamide and the solution of 2-methylpyridine borane complex use a mixture solvent of dimethyl sulfoxide and
- the column is Waters acquity UPLC glycan BEH Amide column (2.1 mm ⁇ 150 mm, 1.7 ⁇ m), and the column temperature is set as 52 °C.
- the excitation and emission wavelengths of the fluorescence detector are 250 nm and 425nm, respectively.
- the method for detecting lactose is as follows: diluting skimmed milk by 10000 times, diluting the permeate by 100 to 5000 times, diluting the retentate by 100 to 5000 times, taking 100 ⁇ L of each diluted sample, to which 50 ⁇ L of a 0.5 M solution of 2-aminobenzamide (serving as a derivative reagent) and a 1 M solution of 2-methylpyridine borane complex (serving as a reductive amination reagent for labelling saccharides) are added respectively, after mixing evenly, carrying out derivation at 65 °C for 2.5 h, then cooling to room temperature, and loading the same into a liquid vial for detection, wherein both the solution of 2-aminobenzamide and the solution of 2-methylpyridine borane complex use a mixture solvent of dimethyl sulfoxide and acetic acid in a volume ratio of 85: 15.
- the column is Waters acquity UPLC glycan BEH Amide column (2.1 mm ⁇ 150 mm, 1.7 ⁇ m), and the column temperature is set at 52 °C.
- the excitation and emission wavelengths of the fluorescence detector are 250 nm and 425nm, respectively.
- SDS-PAGE method diluting a sample, mixing it with 2 ⁇ sample buffer in a volume ratio of 1: 1, and placing the mixture into a boiling water bath for 5 min, and then taking 10 ⁇ L of the mixture for loading.
- the sample voltage is set at 140 V, and electrophoresis is finished when the lower edge of bromophenol blue was 1 cm away from the bottom of the gel.
- Coomassie Brilliant Blue G250 dye is used for dyeing for 1 hour, and a decolorization solution is used for decoloring for 4 hours until the bands are clear, and then imaging is taken.
- the electrophoresis support medium is composed of a gradient gel, such as a precast gel with a concentration of 6 ⁇ 18%.
- SDS-PAGE running solution, the precast gel, the staining solution and the decolorizing solution are all purchased from Nanjing Kingsley Co., Ltd.
- skimmed animal milk generally bovine milk
- the preparation method was as follows.
- raw milk was subjected to pasteurization and skimmed firstly.
- the raw milk was subjected to pasteurization, comprising: heating raw milk at 72 to 85 °C for 15 to 30 s to inhibit the growth and reproduction of microorganisms throughout the production process, while preventing whey protein from denaturing.
- the raw milk was cooled to 45 °C to 55 °C by a plate heat exchanger for skimming, and optionally the skimmed milk was cooled to 1 to 4 °C for storage.
- the temporarily stored skimmed bovine milk needed to be consumed within 6 to 48 hours, and when processed, it was heated to 45 °C to 55 °C by a plate heat exchanger; in the above method, the percentage content of fat in the skimmed bovine milk was less than 0.1% by mass, such as 0.02% to 0.1% by mass, so as to prevent fat globules from blocking microfiltration pores.
- skimmed bovine milk, retentates, and permeates obtained during the membrane separation were detected for oligosaccharides and lactose, and the results were shown in Figure 1 .
- skimmed bovine milk, the microfiltration retentates, and the first, second, third, fourth, and fifth microfiltration permeates obtained during the membrane separation were subjected to SDS-PAGE electrophoresis, wherein the skimmed milk was diluted 10 times, the microfiltration retentate was diluted 26 times, and the microfiltration permeate was diluted 2 times, and the results were shown in Figure 2 .
- the microfiltration permeate contained 91.05% bovine milk oligosaccharides.
- Fig. 2 showed that casein had barely penetrated. This phenomenon fully proved that bovine milk oligosaccharides and whey protein can permeate through the ceramic membrane, thereby realizing their separation from casein, and reducing the pollution of the ultrafiltration membrane in the next step.
- the molecular weight cut-off of the ultrafiltration membrane used in this example was 5 kDa to 30 kDa; optionally, the ultrafiltration membrane was a composite tubular organic membrane.
- the reconstituted desalted whey powder solution, ultrafiltration permeates, and ultrafiltration retentates were subjected to oligosaccharide detection, lactose detection, and SDS-PAGE detection, wherein the ultrafiltration retentate was diluted 4 times, and the oligosaccharide detection results were shown in Figure 3 .
- SDS-PAGE detection results of the reconstituted desalted whey powder solution and its ultrafiltration permeates and retentates were shown in Figure 4 .
- the ultrafiltration permeate from the reconstituted desalted whey powder solution contained 96.92% bovine milk oligosaccharides, which, in combination with Fig. 4 , showed that whey protein was retained to a large extent, fully proving that the used ultrafiltration organic membrane can separate bovine milk oligosaccharides from whey protein and reduce pollution on nanofiltration membrane in the next step.
- the content of bovine milk oligosaccharides in the ultrafiltration permeate can also reach more than 96%, which was similar to the composition of the ultrafiltration permeate from the reconstituted desalted whey powder solution.
- the desalted whey powder was at a far lower cost than raw milk, and was easy to obtain and store. Therefore, the ultrafiltration permeate from the reconstituted desalted whey powder solution was taken as an example for the next procedure.
- the molecular weight cut-off of the nanofiltration membrane used in this example was 100 Da to 3000 Da; optionally, the nanofiltration membrane was a composite tubular organic membrane.
- the nanofiltration retentates were subjected to oligosaccharide detection, and the results were shown in Figure 5 . As can be seen from Fig. 5 , 98.30% bovine milk oligosaccharides were retained in the nanofiltration retentate when the ultrafiltration permeate was concentrated by nanofiltration.
- Example 3 The nanofiltration permeate obtained in Example 3 was concentrated by reverse osmosis in order to obtain deionized water, which was used to supplement the water demand in the process, so as to achieve green production demonstration.
- Example 3 340 L of the nanofiltration permeate obtained in Example 3 was loaded into an ultrafiltration-nanofiltration-reverse osmosis device, and reverse osmosis concentration was carried out for 20 cycles to obtain the primary reverse osmosis permeate, at which time the reverse osmosis concentration was finished.
- the nanofiltration retentate obtained in Example 3 was subjected to chromatographic separation to remove non-prebiotic substances (lactose).
- the chromatographic columns used for three separation methods were Superdex 30 increase pre-loaded column, DEAE-Sepharose FF, and Q-Sepharose FF, respectively, all of which were purchased from Stovan Company.
- these three separation methods can achieve the effective separation of sialyllactose from non-prebiotic substances (lactose), and enable the industrialization of milk oligosaccharides.
- the inventors of the present invention also attempted to separate oligosaccharides from lactose by ANX-Sepharose chromatography, CM-Sepharose FF chromatography, QXL-Sepharose chromatography, SP-Sepharose FF chromatography and SP-Sepharose XL chromatography, but the effects thereof were not ideal, as shown in Comparative example 1 for details.
- Figs. 9-13 effective separation of sialyllactose from non-prebiotic substances cannot be achieved by applying the following five ion chromatographic packings: ANX-Sepharose chromatography, CM-Sepharose FF chromatography, QXL-Sepharose chromatography, SP-Sepharose FF chromatography, and SP-Sepharose XL chromatography.
- the inventors of the present invention also attempted to perform other separation and purification procedures in the research and development process, as shown in Comparative examples 2 to 4 for details.
- Example 3 The nanofiltration retentate in Example 3 was subjected to freeze-drying to obtain a crude milk oligosaccharide powder, 500 mg of the obtained powder and 3 g activated carbon were dissolved in 100 mL of different concentrations of ethanol solutions (5%, 10%, and 15%) to test the optimum concentration for BMO adsorption and lactose desorption. After stirring for 30 minutes, the mixture was filtered under vacuum through Whatman No. 1 filter paper and the activated carbon was washed with 25 mL of the corresponding ethanol solution. Milk oligosaccharides were desorbed from activated carbon with 100 mL ethanol solution (50%, v/v). The mixture was stirred for 30 min and filtered as described above. The filtrate was evaporated at 50 °C under vacuum and the solid was dissolved in 5 mL deionized water. Activated carbon used in this comparative example was purchased from Sigma Aldrich Company.
- the nanofiltration retentate in Example 3 were loaded into dialysis bags with molecular weights of 100-500 Da and 500-1000 Da, respectively, for dialyzing with deionized water at 4 °C for 48 hours.
- the dialysis bags used in the comparative example were purchased from Shanghai Yuanye Co., Ltd.
- the nanofiltration retentate in Example 3 was crystallized to produce lactose mother liquor.
- the nanofiltration retentate was concentrated to 50 ° B 6 by a rotary evaporator, and two fractions of the concentrate were added with 0.02% seed crystal for crystallization at room temperature and 4 °C, respectively, and the other two fractions were crystallized without addition of seed crystal under the same conditions as control.
- the crystalline lactose was rinsed with a small amount of ice water (4 °C). Then, the crystallization conditions were screened based on the yield of oligosaccharide and the removal rate of lactose.
- the lactose seed crystal was purchased from Hilma (USA).
- Example 5 The chromatographic collections of 3'-sialyllactose and 6'-sialyllactose in Example 5 were combined (all of the three chromatographic packing materials in Example 5 can effectively separate milk oligosaccharides, and therefore, one or more chromatographic collections can be taken as an example; in this example, the collection from separation and purification by Q-Sepharose FF was used), and then subjected to nanofiltration for desalination, in which the used membrane unit was 100 Da.
- the above combined collection liquid was loaded into an electrodialysis device for desalination.
- the oligosaccharide detection method was the same as above, in which the above two reagents are used for derivatization and detection.
- Nanofiltration desalination 1100 mL of the above combined collection liquid of Example 5 was loaded into a nanofiltration device with the inlet pressure of 10 bar and the outlet pressure of 5 bar. With the continuous penetration of the permeate, 9 L deionized water was added continuously, and when the conductivity no longer changed, the test was finished and the results were shown in Figure 17 .
- Electrodialysis desalination 1700 mL of the above combined collection liquid of Example 5 was loaded into an electrodialysis device with 8 V of the adjustment voltage, 50 L/h of the material flow rate, 50 L/h of the ultra-pure water flow rate, and 45 L/h of the polar liquid flow rate, and when the electric current no longer changed, the test was finished, and the results were shown in Figure 18 .
- the cumulative desalination rates of the nanofiltration desalination and the electrodialysis desalination were 96.61% and 94.5%, respectively, which indicated that these two methods had better desalination rates, and relatively speaking, the nanofiltration desalination showed higher efficiency without resulting in chemical pollution, thus being the preferred method.
- the desalted milk oligosaccharide solution obtained in Example 6 was subjected to a freeze-drying procedure to obtain the milk oligosaccharide powder.
- the solution was placed on the sample shelf of the freeze dryer for pre-freezing.
- the heating program of vacuum freeze drying was set as: 20 °C for 2 h, 40 °C for 1 h, and 55 °C until to the end.
- the cold trap temperature was set at -50 °C, and the vacuum degree was at 2.50 to 6.50 MPa. The drying was not finished until the moisture content on dry basis was less than 5%.
- the physical image of the bovine milk whey powder was shown in Fig. 19 . As can be seen from Fig. 19 , the bovine milk oligosaccharide powder was white or light yellow in color, uniform in size, and there were no impurities visible.
- the preparation method of the present disclosure comprises the following steps: skimmed milk being subjected to microfiltration concentration to obtain a microfiltration permeate, the microfiltration permeate being then subjected to ultrafiltration to obtain an ultrafiltration permeate (or the reconstituted desalted whey powder solution being subjected to ultrafiltration to obtain the ultrafiltration permeate), the ultrafiltration permeate being then subjected to nanofiltration to obtain a nanofiltration retentate, the nanofiltration permeate being then subjected to reverse osmosis to prepare reverse osmosis water, which is then used in the washing and filtering steps of microfiltration, ultrafiltration, and nanofiltration, thereby forming a series of environment-friendly processes, removing the residual lactose from the nanofiltration retentate by chromatography, subjecting the chromatographic collection liquid to another nanofiltration to obtain the milk oligosaccharide solution, which is then subjected to freeze-drying to obtain the milk oligosaccharide powder.
- the milk oligosaccharide powder is obtained by microfiltration, ultrafiltration, nanofiltration, reverse osmosis, chromatography, and freeze-drying technologies, which do not involve fermentation and enzymatic conversion as compared with that produced by the traditional bioengineering technology, and thereby remain the natural structure of milk oligosaccharides. Additionally, it has excellent processing quality characteristics and pure flavor, and shows wide application prospects in food industry.
- the present disclosure provides a method for preparing milk oligosaccharides, and milk oligosaccharide powder and food prepared by the same, wherein the method comprises the following steps of: performing ultrafiltration of whey liquid for at least three times, subjecting the ultrafiltration permeate to nanofiltration concentration for several times, then subjecting the nanofiltration retentate to chromatographic separation and purification, collecting chromatographic collection liquid containing sialyllactose while removing the fraction containing lactose, subjecting the collection to desalination and drying to obtain the oligosaccharide powder.
- the milk oligosaccharides prepared by the present invention and the food products containing the same comprise basically bovine milk oligosaccharides, which are light yellow or white in color, light in flavor, uniform in size, and have good thermal stability and solubility.
- the milk oligosaccharides mainly comprise 3'-sialyllactose and 6'-sialyllactose.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Nanotechnology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Materials Engineering (AREA)
- Urology & Nephrology (AREA)
- Inorganic Chemistry (AREA)
- Sustainable Development (AREA)
- Pediatric Medicine (AREA)
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
- The present application claims priority to
Chinese patent application No. 202111649065.5 filed with the CNIPA on Dec. 29, 2021 - The present application relates to the technical field of further processing of dairy products, and in particular to a preparation method of milk oligosaccharides, and oligosaccharide powder and food prepared thereby.
- Breast milk is the only source of nutrition for newborns in the first stage of life. For centuries, breast milk has continuously evolved to nourish newborns and is regarded as the "gold standard" of nutrition for term babies. Human milk oligosaccharides (HMOs) are abundant and unique in breast milk, but have been neglected in nutrition for many years. At present, more than 200 components have been detected, of which more than 100 structures have been clarified.
- Human milk oligosaccharides are of great structural diversity. There are great variations in both concentration and composition between individuals and during lactation period. They appear as free structures or combine with macromolecules such as glycoproteins and glycolipids. The structure of HMO mainly consists of five monomers: glucose, galactose, N-acetylglucosamine, fucose and N-acetyl neuraminic acid, each HMO comprising a lactose residue as its core, which can be elongated by repeated lactosamine units to form a straight or branched chain structure. The formed linear or branched chain structure can be further elongated in the presence of fucosyl transferase and sialic acid transferase to form a fucosylated and sialylated oligosaccharide.
- HMOs, initially discovered as a "bifidus factor", can be used as a metabolic substrate for desired bacteria and contribute to the formation of dominant intestinal flora. Nowadays, more and more evidences have shown that HMOs also play a role in anti-adhesion, anti-bacteria, regulation of intestinal epithelium and immune cells, reduction of excessive mucosal leukocyte infiltration and activation, reduction of neonatal necrotizing enterocolitis, and provision of sialic acid as a potential necessary nutrient for brain development and cognition of infants. Therefore, the World Health Organization recommends that infants are exclusively breastfed for the first 6 months after birth. However, according to the Report on National Survey into Factors Influencing Breastfeeding released by China Development Research Foundation in February 2019, the rate of exclusive breastfeeding for the first 6 months of life was only 29.2%, which still fell short of the goal of 50% by 2020 set forth in the Outline for the Development of Chinese Children (2011-2020) and the National Nutrition Plan (2017-2030), and was far below the world average level of 43% as well as the average level of 37% for low- and middle-income countries. The low rate of breastfeeding in China is mainly caused by insufficient public awareness of breastfeeding, short maternity leave, lack of maternal and child rooms, lack of breast milk, occupation or illness of their own, etc. The infant formula provides sufficient nutrients for babies who are insufficiently breastfed or cannot be breastfeed. Since human milk oligosaccharides cannot be produced on a large scale, galactooligosaccharides and fructooligosaccharides are usually added to infant formula, which however does not contain fucose, sialic acid, and N-acetylglucosamine monomers present in human milk oligosaccharides, as demonstrated by studies.
- It is a great progress to add 1 to 6 human milk oligosaccharide monomers to infant formula, and in vitro, in vivo, and clinical trials have proved that the human milk oligosaccharides have safety and immune effect. At present, high-pure human milk oligosaccharide monomer molecules (2'-fucosyllactose, difucosyllactose, lactose-A-tetrasaccharide, lactose-N-neotetrasaccharide, 3'-sialolactose, and 6'-sialolactose) have been approved by the European Union and the US Food and Drug Administration and can be used as supplements for infant formula. However, only addition of one or several human milk oligosaccharide monomers cannot simulate the complex structure of human milk oligosaccharides.
- In recent years, membrane separation technology has developed rapidly and has been widely used in various industries due to the advantages of energy saving, consumption reduction, no phase change, and no pollution, and has been widely used in dairy industry, such as microfiltration sterilization, skim milk separation, whey separation, lactose concentration, reverse osmosis to remove water, etc., which shows incomparable advantages over traditional methods, and can realize the real recycling of by-products. Among them, the application of membrane technology to sterilization of milk and separation of milk components such as whey protein, casein, α-lactalbumin, β-lactoglobulin, α-casein, and β-casein has become a hot topic at home and abroad. Membrane separation technology is an environmentally friendly physical separation process, consumes less energy, compared with rotary, single-effect or multi-effect evaporation, freeze-drying, or spray drying, and does not need to add any toxic and harmful organic reagents in the separation process. Moreover, the operation temperature is low, which is especially suitable for heat-sensitive components, and will not destroy the natural structures of proteins, lactoses, and oligosaccharides, thus producing products with better functional characteristics. It shows more application value and a great practical prospect in dairy processing.
- Bovine whey is a by-product produced in cheese manufacturing or a natural permeate prepared by microfiltration, which is usually discharged as waste liquid or prepared by spray drying into whey powder for sale at low prices. Compared with other livestock milk, it has the advantages of large quantity and low cost. Therefore, it is of great significance to extract bovine milk oligosaccharides from whey (including sweet whey, reconstituted desalted whey, microfiltration permeate of milk, etc.) on a large scale for use as a substitute for human milk oligosaccharides. At present, no substitute for human milk oligosaccharide has been obtained from milk of any animal origin to meet the commercial demand.
- In order to overcome the above shortcomings, the present disclosure provides a method for preparing milk oligosaccharides, and oligosaccharide powder and food prepared by the method.
- Animal milk oligosaccharides, especially bovine milk oligosaccharides, are new ingredients imitating human milk oligosaccharides, and are similar to human milk oligosaccharides in structure and biological function. Therefore, by applying bovine milk oligosaccharides in replacement of galactooligosaccharide and fructooligosaccharide in functional foods such as infant formula and special medicine, it can not only produce health value, but also has the opportunity to obtain higher additive values in dairy products that are not fully utilized at present.
- In order to achieve the purpose of the invention, the present disclosure provides technical solutions as follows:
In a first aspect, the present disclosure provides a method for preparing milk oligosaccharides, which comprises the following steps: performing ultrafiltration of whey liquid for at least three times, subjecting the ultrafiltration permeate to nanofiltration concentration for several times, then subjecting the nanofiltration retentate to chromatographic separation and purification, collecting chromatographic collection liquid containing sialyllactose while removing the fraction containing lactose, subjecting the collection to desalination and drying to obtain oligosaccharide powder. - Further, the procedure of collecting chromatographic collection liquid containing sialyllactose comprises: collecting chromatographic collection liquid into a tube and performing detections on the same, and combining the chromatographic collection liquid containing sialyllactose, in which the detection of sialyllactose is performed by the oligosaccharide detection method.
- Further, the drying procedure is performed by freeze drying; optionally, the freeze-drying step comprises: loading the desalted concentrated retentate into a freeze dryer for drying; further optionally, the freeze-drying step comprises: setting the heating program of the vacuum freeze-drying as: 20°C for 2 h, 40°C for 1 h, and 55°C until to the end, with the cold trap temperature being set at -50°C, and the vacuum degree at 2.50 to 6.50 MPa; and the drying procedure is not finished until the moisture content on dry basis is less than 5%.
- Further, in the procedure of chromatographic separation and purification, the chromatographic packing material uses a cross-linked complex of agarose and dextran or a cross-linked agarose as the carrier; optionally, the carrier of the chromatographic packing material is Superdex 30 increase pre-loaded column, or DEAE-Sepharose Fast Flow, or Q-Sepharose Fast Flow; optionally, the procedure of chromatographic separation and purification comprises:
- loading the nanofiltration retentate into Superdex 30 increase pre-loaded column at a flow rate of 0.5 to 0.8 mL/min, and collecting the effluent at 0.5 to 2 mL/tube; optionally, the flow rate is 0.6 mL/min, and the collection of the effluent is performed at 1 mL/tube;
- or, loading the nanofiltration retentate into a 1.5 cm × 20 cm DEAE-Sepharose FF column at a flow rate of 1 to 2 mL/min, and collecting the effluent at 0.5-1.5 mL/tube; optionally, the flow rate is 1.5 mL/min, and the collection of the effluent is performed at 1 mL/tube;
- or, loading the nanofiltration retentate into a 10 cm × 50 cm Q-Sepharose FF column at a flow rate of 15 to 25 mL/min, and collecting the effluent at 40 to 60 mL/tube; optionally, the flow rate is 20 mL/min, and the collection of the effluent is performed at 50 mL/tube.
- The chromatographic packing material used in the present disclosure has the advantages of heat resistance, pressure resistance, high resolution, high chemical stability, high flow rate, high load, ease to in-situ cleaning, reusability, low nonspecific adsorption, and high recovery rate, and is suitable for industrial scale production.
- Further, the whey liquid is a by-product whey liquid produced during cheese manufacturing, or a whey liquid after the desalted whey powder is reconstituted, or a permeate prepared by microfiltration of skimmed animal milk, in which, optionally, the animal milk is bovine milk; and
- optionally, the mass ratio of the desalted whey powder to water is 1: 4 to 20;
- optionally, the method of preparing the permeate from the animal milk by microfiltration comprises: subjecting the skimmed animal milk to microfiltration for at least three times to obtain the microfiltration permeate; optionally, the percentage content of fat in the skimmed animal milk is less than or equal to 0.1% by mass, and preferably is 0.02% to 0.1% by mass;
- optionally, the animal milk skimming procedure comprises: subjecting the raw milk to pasteurization and then cooling to 45 to 55°C through a plate heat exchanger for skimming; optionally, the microfiltration for at least three times comprises: concentrating the skimmed animal milk through microfiltration until reaching 2 to 5 cycles of concentration to obtain the first microfiltration permeate; diluting the first microfiltration retentate with water, followed by concentrating through microfiltration until reaching 2 to 5 cycles of concentration to obtain the second microfiltration permeate; diluting the second microfiltration retentate with water, followed by concentrating through microfiltration until reaching 2 to 5 cycles of concentration to obtain the third microfiltration permeate, and so on; optionally, the microfiltration is performed five times; optionally, dilution with water is carried out until the quality is similar to that of the skimmed animal milk before microfiltration;
- optionally, in the concentration through microfiltration, the used microfiltration membrane has a pore diameter of 50 nm to 140 nm; optionally, a tubular ceramic membrane is used as the microfiltration membrane; the ceramic membrane has the advantages of high separation efficiency, stable effect, good chemical stability, acid and alkali resistance, organic solvent resistance, bacteria resistance, high temperature resistance, pollution resistance, high mechanical strength, and good regeneration performance, and the separation process is simple, has low energy consumption, and is easy in operation and maintenance, thus being an environmentally friendly technology.
- Optionally, the microfiltration is performed under conditions as follows: the feed temperature is 45 °C to 55 °C, the inlet pressure is 2 to 5 bar, the outlet pressure is 1 to 4 bar, the back pressure is 0.5 to 3 bar, and the membrane pressure difference is less than 3 bar. It is noted that if the pressure is too high, the membrane will be blocked seriously, and the concentration polarization will be accelerated, which will affect the permeability of bovine milk oligosaccharides. In addition, too large or too small membrane pressure difference will lead to low separation efficiency, time-consuming and energy-consuming, and susceptibility to microbial contamination.
- In the present disclosure, the purpose of multiple microfiltrations of skimmed animal milk is to remove casein from the skimmed milk, so as to prevent contamination of the ultrafiltration membrane in the next stage, while separating more milk oligosaccharides.
- Further, the ultrafiltration for at least three times comprises: concentrating the microfiltration permeate through ultrafiltration until reaching 2 to 7 cycles of concentration to obtain the first ultrafiltration permeate; diluting the first ultrafiltration retentate with water, followed by concentrating through ultrafiltration until reaching 2 to 7 cycles of concentration to obtain the second ultrafiltration permeate; diluting the second ultrafiltration retentate with water, followed by concentrating through ultrafiltration until reaching 2 to 7 cycles of concentration to obtain the third ultrafiltration permeate, and so on; optionally, the ultrafiltration is performed six times; optionally, the amount of water added for dilution is similar to the mass of ultrafiltration retentate to be diluted.
- Further, in the ultrafiltration procedure, the used ultrafiltration membrane has a molecular weight cut-off of 5 kDa to 30 kDa; optionally, the ultrafiltration membrane is a composite tubular organic membrane. Organic membranes have the advantages of large effective membrane area, low price, low investment, uniform pore size distribution, and ease to operation and cleaning.
- Further, the ultrafiltration is performed under conditions as follows: the feed temperature is 20 °C to 45 °C, the inlet pressure is 6 to 9 bar, the outlet pressure is 5 to 8 bar; optionally, the membrane pressure difference is not more than 3 bar.
- Further, the procedure of nanofiltration concentration for several times comprises: concentrating the ultrafiltration permeate through nanofiltration until reaching 2 to 13 cycles of concentration to obtain the first nanofiltration retentate; diluting the first nanofiltration retentate with water, followed by concentrating through nanofiltration until reaching 2 to 13 cycles of concentration to obtain the second nanofiltration retentate; diluting the second nanofiltration retentate with water, followed by concentrating through nanofiltration until reaching 2 to 13 cycles of concentration to obtain the third nanofiltration retentate, and so on; alternatively, the nanofiltration is performed six times; optionally, the amount of water added for dilution is similar to that of nanofiltration retentate to be diluted.
- Further, in the nanofiltration procedure, the used nanofiltration membrane has a molecular weight cut-off of 100 Da to 3000 Da; optionally, the nanofiltration membrane used in the nanofiltration step is a composite tubular organic membrane.
- Further, the nanofiltration is performed under conditions as follows: the feed temperature is 20 °C to 45 °C, the inlet pressure is 16 to 20 bar, the outlet pressure is 14 to 18 bar; optionally, the membrane pressure difference is not more than 3 bar.
- Further, the desalination is performed by nanofiltration or electrodialysis;
- optionally, the desalination by nanofiltration comprises: separating the chromatographic collection liquid through nanofiltration, washing and filtering with deionized water until the conductivity does not decrease any longer, and concentrating to the minimum cycling volume of the device to obtain a concentrated nanofiltration retentate, at which time the nanofiltration concentration is finished; optionally, the nanofiltration membrane used in the desalination by nanofiltration has a molecular weight cut-off of 100 Da to 500 Da; optionally, the nanofiltration membrane used in the desalination by nanofiltration is a composite tubular organic membrane; optionally, the desalination by nanofiltration is performed under the conditions as follows: the feed temperature is 20 °C to 45 °C, the inlet pressure is 10 to 15 bar, and the outlet pressure is 5 to 10 bar; optionally, the membrane pressure difference is not more than 3 bar;
- optionally, the electrodialysis procedure comprises: loading the chromatographic collection liquid into an electrodialysis device for dialysis until the electric current does not change any longer, at which time the desalination is finished; optionally, the electrodialysis is performed under conditions as follows: regulation voltage: 8 V, feed flow rate: 50 L/h, ultra-pure water flow rate: 50 L/h, polar liquid flow rate: 45 L/h.
- Further, the method of the present application further comprises: concentrating the nanofiltration permeate by reverse osmosis to generate deionized water suitable for the process;
- optionally, the concentration by reverse osmosis specifically comprises: concentrating the nanofiltration permeate by reverse osmosis to the minimum cycling volume of the device to obtain a reverse osmosis permeate, at which time the reverse osmosis is finished;
- optionally, in the reverse osmosis procedure, the used membrane has a stable desalination rate of 99.5%;
- optionally, the reverse osmosis is performed under conditions as follows: the feed temperature is 20 °C to 45 °C, the inlet pressure is 16 to 20 bar, the outlet pressure is 14 to 18 bar; optionally, the membrane pressure difference is not more than 3 bar.
- Further, the procedures of ultrafiltration, nanofiltration, and reverse osmosis adopt an integrated ultrafiltration-nanofiltration-reverse osmosis device.
- On the other hand, the invention provides an oligosaccharide powder, which is a milk oligosaccharide powder prepared by the present method; optionally, the milk oligosaccharide powder comprises sialyllactose; optionally, the sialyllactose comprises 3'-sialyllactose and 6'-sialyllactose; optionally, the total percentage content of 3'-sialyllactose and 6'-sialyllactose in the milk oligosaccharide powder is not less than 25% by mass.
- In another aspect, the invention provides an oligosaccharide food or health product, which comprises the oligosaccharide powder prepared by the present method or the oligosaccharide powder as described above.
- The oligosaccharide food or health product comprises an oligosaccharide powder prepared by the present method; optionally, the oligosaccharide powder comprises sialyllactose, which optionally comprises 3'-sialyllactose and 6'-sialyllactose.
-
- (1) According to the present application, ultrafiltration is performed at least three times, which can effectively remove whey protein from whey liquid, avoid polluting the nanofiltration membrane in the next stage, and separate more milk oligosaccharides; multiple nanofiltration concentrations have been applied, which can remove water and some lactose, minimize the interference of non-prebiotic components, while increasing the dry matter content; separation by chromatography is to remove residual lactose, so as to obtain a product mainly containing sialyloligosaccharides, and desalination is applied to remove NaCl introduced in chromatography.
- (2) The milk oligosaccharides prepared by the present method and the food product containing the milk oligosaccharide comprise basically natural bovine milk oligosaccharides, which are light yellow or white in color, light in flavor, uniform in size, and have good thermal stability and solubility. The milk oligosaccharides mainly comprise 3'-sialyllactose and 6'-sialyllactose.
- (3) According to the present application, the milk oligosaccharide powder is obtained by microfiltration, ultrafiltration, nanofiltration, reverse osmosis, chromatography, and freeze-drying technologies, which do not involve fermentation and enzymatic conversion as compared with the traditional bioengineering technology, and thereby remain the natural structure of milk oligosaccharides. Additionally, it has excellent processing quality characteristics and pure flavor, and shows wide application prospects in food industry.
- One or more examples are exemplified by the pictures in the accompanying drawings that correspond thereto and are not intended to be limiting of the embodiments. As used herein, the word "exemplary" means "serving as an example, embodiment, or illustrative". Any embodiment described herein as "exemplary" is not necessarily to be construed as superior or better than other embodiments.
-
Fig. 1 is a histogram showing bovine milk oligosaccharide permeation rate for each stage of the microfiltration procedure in Example 1 of the present application; -
Fig. 2 shows the results of sodium dodecyl sulphate-polyacrylamide gel electrophoresis of the skimmed bovine milk, microfiltration permeates and microfiltration retentates, ultrafiltration permeates and ultrafiltration retentates obtained during the separation of the skimmed bovine milk by membrane technology, as recited in Examples 1 and 2 of the present application; -
Fig. 3 is a histogram showing bovine milk oligosaccharide permeation rate for each stage of the ultrafiltration procedure of reconstituted desalted whey powder solution in Example 2 of the present application; -
Fig. 4 shows the results of sodium dodecyl sulphate-polyacrylamide gel electrophoresis of reconstituted desalted whey powder solution, ultrafiltration permeates, and ultrafiltration retentates obtained during the separation of the reconstituted desalted whey powder solution by membrane technology, as recited in Example 2 of the present application; -
Fig. 5 is a histogram showing bovine milk oligosaccharide retention rate for each stage of the nanofiltration procedure in Example 3 of the present application; -
Fig. 6 is a diagram showing the separation and purification of nanofiltration retentate bySuperdex 30 increase pre-loaded column in Example 5 of the present application; -
Fig. 7 is a diagram showing the separation and purification of nanofiltration retentate by DEAE-Sepharose FF in Example 5 of the present application; -
Fig. 8 is a diagram showing the separation and purification of nanofiltration retentate by Q-Sepharose FF in Example 5 of the present application; -
Fig. 9 is a diagram showing the separation and purification of nanofiltration retentate by ANX-Sepharose chromatography in Comparative example 1; -
Fig. 10 is a diagram showing the separation and purification of nanofiltration retentate by CM-Sepharose FF chromatography in Comparative example 1 of the present invention; -
Fig. 11 is a diagram showing the separation and purification of nanofiltration retentate by QXL-Sepharose chromatography in Comparative example 1 of the present invention; -
Fig. 12 is a diagram showing the separation and purification of nanofiltration retentate by SP-Sepharose FF chromatography in Comparative example 1; -
Fig. 13 is a diagram showing the separation and purification of nanofiltration retentate by SP-Sepharose XL chromatography in Comparative example 1 of the present invention; -
Fig. 14 shows the recovery rate of oligosaccharides and the removal rate of lactose by activated carbon in Comparative example 2; -
Fig. 15 shows the recovery rate of oligosaccharides and the removal rate of lactose by dialysis bags with different molecular weights in Comparative example 3; -
Fig. 16 shows the recovery rate of bovine milk oligosaccharides and the removal rate of lactose by different crystallization methods in Comparative example 4; -
Fig. 17 is a histogram showing the nanofiltration desalination rate in the desalination process of Example 6 of the present application; -
Fig. 18 is a histogram showing the electrodialysis desalination rate in the desalination process of Example 6 of the present application; in which, conductivity: mS/cm, current: A, voltage: V, column volume height: cm. -
Fig. 19 is an image of bovine milk oligosaccharide powder of Example 7 of the present application. - In order to make the purpose, technical solutions and advantages of the invention clearer, the technical solutions in the embodiments of the invention will be described clearly and completely, obviously, the described embodiments are some of the embodiments of the present invention, but not all of them. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative work are within the scope of the present invention.
- In addition, in order to better explain the present invention, a lot of specific details are given in the following embodiments. It will be understood by those skilled in the art that the present invention may be practiced without certain specific details. In some embodiments, materials, elements, methods, means, etc., well known to those skilled in the art, are not described in detail so as to highlight the spirit of the present invention.
- Throughout the specification and claims, the term "comprising" or variations thereof, such as "including" or "containing", will be understood to include the stated components and not to exclude other elements or other components, unless expressly indicated otherwise.
- There is no cross relationship between the separately mentioned term "lactose" and the term "sialyllactose" in the present disclosure. The separately mentioned term "lactose" in the present disclosure refers to 1,4-galactoside glucose, while the term "sialyllactose" belongs to prebiotic oligosaccharides. The oligosaccharides separated from whey liquid in the present application mainly comprise sialyllactose.
- The present disclosure provides a method for preparing milk oligosaccharides by using whey liquid as raw material, which can be originated from the following three sources: 1) whey liquid as a by-product produced during cheese manufacturing; 2) whey liquid obtained after reconstitution of desalted whey powder; 3) the permeate prepared by microfiltration of the skimmed animal milk (usually bovine milk);
- Among them, whey liquid as a by-product produced during cheese manufacturing, or whey liquid obtained after reconstitution of desalted whey powder can be subjected to ultrafiltration directly or after a simple filtration; generally, the whey liquid obtained after reconstitution of desalted whey powder is prepared by using desalted whey powder and water at the mass ratio of 1: 4 to 20.
- In the following examples and comparative examples, lactose and bovine milk oligosaccharides are detected as follows:
The method for detecting bovine milk oligosaccharides is as follows: diluting skimmed milk by 100 times, diluting the permeate by 2 times, after passing through 0.22 µm nylon filter membrane, taking 100 µL of stock solution or 100 µL of the separated oligosaccharide sample, to which 50 µL of a 0.5 M solution of 2-aminobenzamide (serving as a derivative reagent) and a 1 M solution of 2-methylpyridine borane complex (serving as a reductive amination reagent for labelling saccharides) are added respectively, after mixing evenly, carrying out derivation at 65 °C for 2.5 h, then cooling to room temperature, and loading the same into a liquid vial for detection, wherein both the solution of 2-aminobenzamide and the solution of 2-methylpyridine borane complex use a mixture solvent of dimethyl sulfoxide and acetic acid in a volume ratio of 85: 15. Among them, the mobile phase is 100 mmol ammonium formate solution (pH=4.5) and acetonitrile solution. The column is Waters acquity UPLC glycan BEH Amide column (2.1 mm × 150 mm, 1.7 µm), and the column temperature is set as 52 °C. The excitation and emission wavelengths of the fluorescence detector are 250 nm and 425nm, respectively. - The method for detecting lactose is as follows: diluting skimmed milk by 10000 times, diluting the permeate by 100 to 5000 times, diluting the retentate by 100 to 5000 times, taking 100 µL of each diluted sample, to which 50 µL of a 0.5 M solution of 2-aminobenzamide (serving as a derivative reagent) and a 1 M solution of 2-methylpyridine borane complex (serving as a reductive amination reagent for labelling saccharides) are added respectively, after mixing evenly, carrying out derivation at 65 °C for 2.5 h, then cooling to room temperature, and loading the same into a liquid vial for detection, wherein both the solution of 2-aminobenzamide and the solution of 2-methylpyridine borane complex use a mixture solvent of dimethyl sulfoxide and acetic acid in a volume ratio of 85: 15. Among them, the mobile phase is 100 mmol ammonium formate solution (pH=4. 5) and acetonitrile solution. The column is Waters acquity UPLC glycan BEH Amide column (2.1 mm × 150 mm, 1.7 µm), and the column temperature is set at 52 °C. The excitation and emission wavelengths of the fluorescence detector are 250 nm and 425nm, respectively.
- SDS-PAGE method: diluting a sample, mixing it with 2 × sample buffer in a volume ratio of 1: 1, and placing the mixture into a boiling water bath for 5 min, and then taking 10 µL of the mixture for loading. The sample voltage is set at 140 V, and electrophoresis is finished when the lower edge of bromophenol blue was 1 cm away from the bottom of the gel. After electrophoresis, Coomassie Brilliant Blue G250 dye is used for dyeing for 1 hour, and a decolorization solution is used for decoloring for 4 hours until the bands are clear, and then imaging is taken. Among them, the electrophoresis support medium is composed of a gradient gel, such as a precast gel with a concentration of 6 ~ 18%. Among them, SDS-PAGE running solution, the precast gel, the staining solution and the decolorizing solution are all purchased from Nanjing Kingsley Co., Ltd.
- When taking the permeate prepared by microfiltration of skimmed animal milk (generally bovine milk) as the whey liquid, the preparation method was as follows.
- In general, raw milk was subjected to pasteurization and skimmed firstly. Specifically, the raw milk was subjected to pasteurization, comprising: heating raw milk at 72 to 85 °C for 15 to 30 s to inhibit the growth and reproduction of microorganisms throughout the production process, while preventing whey protein from denaturing. After sterilization, the raw milk was cooled to 45 °C to 55 °C by a plate heat exchanger for skimming, and optionally the skimmed milk was cooled to 1 to 4 °C for storage. The temporarily stored skimmed bovine milk needed to be consumed within 6 to 48 hours, and when processed, it was heated to 45 °C to 55 °C by a plate heat exchanger; in the above method, the percentage content of fat in the skimmed bovine milk was less than 0.1% by mass, such as 0.02% to 0.1% by mass, so as to prevent fat globules from blocking microfiltration pores.
- One embodiment of microfiltration of skimmed bovine milk was operated as follows:
- (1) microfiltration concentration for five times: loading 48 L skimmed bovine milk into a microfiltration device, and stabilizing the temperature at 50 °C by using the refrigerant device; using a tubular ceramic membrane with pore size of 100 nm as the membrane material; wherein, the inlet pressure was 5 bar, the outlet pressure was 4 bar, and the back pressure was 3 bar.
- The skimmed bovine milk was concentrated through microfiltration until reaching 3 cycles of concentration to obtain the first microfiltration permeate, at which time the first microfiltration was finished;
- 32 kg of deionized water was added at one time until the total mass of the added water and the first microfiltration retentate was equal to that of the original skimmed bovine milk, and then the diluted first microfiltration retentate was concentrated through microfiltration until reaching 3 cycles of concentration to obtain the second microfiltration permeate, at which time the second microfiltration was finished;
- 32 kg of deionized water was again added at one time until the total mass of the added water and the second microfiltration retentate was equal to that of the original skimmed bovine milk, and then the diluted second microfiltration retentate was concentrated through microfiltration until reaching 3 cycles of concentration to obtain the third microfiltration permeate, at which time the third microfiltration was finished;
- 32 kg of deionized water was again added at one time until the total mass of the added water and the third microfiltration retentate was equal to that of the original skimmed bovine milk, and then the diluted third microfiltration retentate was concentrated through microfiltration until reaching 3 cycles of concentration to obtain the fourth microfiltration permeate, at which time the fourth microfiltration was finished;
- 32 kg of deionized water was again added at one time until the total mass of the added water and the fourth microfiltration retentate was equal to that of the original skimmed bovine milk, and then the diluted fourth microfiltration retentate was concentrated through microfiltration until reaching 3 cycles of concentration, at which time the fifth microfiltration was finished, and a total of 160 kg microfiltration permeate was obtained.
- The skimmed bovine milk, retentates, and permeates obtained during the membrane separation were detected for oligosaccharides and lactose, and the results were shown in
Figure 1 . - In addition, the skimmed bovine milk, the microfiltration retentates, and the first, second, third, fourth, and fifth microfiltration permeates obtained during the membrane separation were subjected to SDS-PAGE electrophoresis, wherein the skimmed milk was diluted 10 times, the microfiltration retentate was diluted 26 times, and the microfiltration permeate was diluted 2 times, and the results were shown in
Figure 2 . - As seen from
Fig. 1 , compared with the skimmed bovine milk, the microfiltration permeate contained 91.05% bovine milk oligosaccharides.Fig. 2 showed that casein had barely penetrated. This phenomenon fully proved that bovine milk oligosaccharides and whey protein can permeate through the ceramic membrane, thereby realizing their separation from casein, and reducing the pollution of the ultrafiltration membrane in the next step. -
- 160 L of microfiltration permeate obtained in Example 1 was loaded into an integrated ultrafiltration-nanofiltration-reverse osmosis device,
- or 8 kg of desalted whey powder was dissolved in deionized water to a constant volume of 160 L and then loaded into an integrated ultrafiltration-nanofiltration-reverse osmosis device,
- the reconstituted desalted whey powder solution was subjected to the following ultrafiltration operations, respectively:
- the solution was concentrated through ultrafiltration until reaching 6.4 cycles of concentration to obtain the first ultrafiltration permeate, at which time the first ultrafiltration was finished;
- 25 kg of deionized water was added at one time, and then ultrafiltration concentration was performed until reaching 2 cycles of concentration to obtain the second ultrafiltration permeate, at which time the second ultrafiltration was finished;
- 25 kg of deionized water was again added at one time, and then ultrafiltration concentration was performed until reaching 2 cycles of concentration to obtain the third ultrafiltration permeate, at which time the third ultrafiltration was finished;
- 25 kg of deionized water was again added at one time, and then ultrafiltration concentration was performed until reaching 2 cycles of concentration to obtain the fourth ultrafiltration permeate, at which time the fourth ultrafiltration was finished;
- 25 kg of deionized water was again added at one time, and then ultrafiltration concentration was performed until reaching 2 cycles of concentration to obtain the fifth ultrafiltration permeate, at which time the fifth ultrafiltration was finished;
- 25 kg of deionized water was again added at one time, and then ultrafiltration concentration was performed until reaching 2 cycles of concentration, at which time the sixth ultrafiltration was finished, and a total of 260 kg of ultrafiltration permeate was obtained.
- The molecular weight cut-off of the ultrafiltration membrane used in this example was 5 kDa to 30 kDa; optionally, the ultrafiltration membrane was a composite tubular organic membrane.
- The reconstituted desalted whey powder solution, ultrafiltration permeates, and ultrafiltration retentates were subjected to oligosaccharide detection, lactose detection, and SDS-PAGE detection, wherein the ultrafiltration retentate was diluted 4 times, and the oligosaccharide detection results were shown in
Figure 3 . SDS-PAGE detection results of the reconstituted desalted whey powder solution and its ultrafiltration permeates and retentates were shown inFigure 4 . - As can be seen from
Fig. 3 , the ultrafiltration permeate from the reconstituted desalted whey powder solution contained 96.92% bovine milk oligosaccharides, which, in combination withFig. 4 , showed that whey protein was retained to a large extent, fully proving that the used ultrafiltration organic membrane can separate bovine milk oligosaccharides from whey protein and reduce pollution on nanofiltration membrane in the next step. - After ultrafiltration of the microfiltration permeate of skimmed bovine milk, the content of bovine milk oligosaccharides in the ultrafiltration permeate can also reach more than 96%, which was similar to the composition of the ultrafiltration permeate from the reconstituted desalted whey powder solution. Moreover, the desalted whey powder was at a far lower cost than raw milk, and was easy to obtain and store. Therefore, the ultrafiltration permeate from the reconstituted desalted whey powder solution was taken as an example for the next procedure.
-
- 260 kg of ultrafiltration permeate of the reconstituted desalted whey powder solution obtained in Example 2 was loaded into an ultrafiltration-nanofiltration-reverse osmosis device to remove excess water, and the ultrafiltration permeate was concentrated through nanofiltration until reaching 13 cycles of concentration to obtain the first nanofiltration retentate, at which time the first nanofiltration was finished;
- 20 kg of deionized water was added at one time, and nanofiltration concentration was performed until reaching 2 cycles of concentration to obtain the second nanofiltration retentate, at which time the second nanofiltration was finished;
- 20 kg of deionized water was again added at one time, and nanofiltration concentration was performed until reaching 2 cycles of concentration to obtain the third nanofiltration retentate, at which time the third nanofiltration was finished;
- 20 kg of deionized water was again added at one time, and nanofiltration concentration was performed until reaching 2 cycles of concentration to obtain the fourth nanofiltration retentate, at which time the fourth nanofiltration was finished;
- 20 kg of deionized water was again added at one time, and nanofiltration concentration was performed until reaching 2 cycles of concentration to obtain the fifth nanofiltration retentate, at which time the fifth nanofiltration was finished;
- 20 kg of deionized water was again added at one time, and nanofiltration concentration was performed until reaching 2 cycles of concentration, at which time the sixth nanofiltration was finished, and a total of 17 kg nanofiltration retentate was obtained.
- The molecular weight cut-off of the nanofiltration membrane used in this example was 100 Da to 3000 Da; optionally, the nanofiltration membrane was a composite tubular organic membrane. The nanofiltration retentates were subjected to oligosaccharide detection, and the results were shown in
Figure 5 . As can be seen fromFig. 5 , 98.30% bovine milk oligosaccharides were retained in the nanofiltration retentate when the ultrafiltration permeate was concentrated by nanofiltration. - The nanofiltration permeate obtained in Example 3 was concentrated by reverse osmosis in order to obtain deionized water, which was used to supplement the water demand in the process, so as to achieve green production demonstration.
- 340 L of the nanofiltration permeate obtained in Example 3 was loaded into an ultrafiltration-nanofiltration-reverse osmosis device, and reverse osmosis concentration was carried out for 20 cycles to obtain the primary reverse osmosis permeate, at which time the reverse osmosis concentration was finished.
- The results showed that the conductivity of water produced by the reverse osmosis was 2 to 5 uS/cm, which can meet the water demand in the process, can be circulated, and has no pollution and no harmful substances residue throughout the process.
- The nanofiltration retentate obtained in Example 3 was subjected to chromatographic separation to remove non-prebiotic substances (lactose). The chromatographic columns used for three separation methods were
Superdex 30 increase pre-loaded column, DEAE-Sepharose FF, and Q-Sepharose FF, respectively, all of which were purchased from Stovan Company. - a) 500 µL of nanofiltration retentate obtained in Example 3 was loaded into
Superdex 30 increase pre-loaded column for chromatographic separation, wherein, the flow rate was 0.6 mL/min, and the effluent was collected into tube at 1 mL/tube; the collection in each tube was subjected to oligosaccharide detection and lactose detection, and the results were shown inFigure 6 . - b) 500 µL of nanofiltration retentate obtained in Example 3 was loaded into DEAE-Sepharose FF chromatographic column (1.5 cm × 20 cm) for chromatographic separation, wherein, the flow rate was 1.5 mL/min, and the effluent was collected into tube at 1 mL/tube; the collection in each tube was subjected to oligosaccharide detection and lactose detection, and the results were shown in
Figure 7 . - c) 1 L of nanofiltration retentate obtained in Example 3 was loaded into Q-Sepharose FF (10 cm × 50 cm) for chromatographic separation, wherein, the flow rate was 20 mL/min, and the effluent was collected into tube at 50 mL/tube; the collection in each tube was subjected to oligosaccharide detection and lactose detection, and the detection results were shown in
Figure 8 . - As can be seen from
Figs. 6-8 , these three separation methods can achieve the effective separation of sialyllactose from non-prebiotic substances (lactose), and enable the industrialization of milk oligosaccharides. - In the research and development process, the inventors of the present invention also attempted to separate oligosaccharides from lactose by ANX-Sepharose chromatography, CM-Sepharose FF chromatography, QXL-Sepharose chromatography, SP-Sepharose FF chromatography and SP-Sepharose XL chromatography, but the effects thereof were not ideal, as shown in Comparative example 1 for details.
-
- 1) 100 µL of nanofiltration retentate obtained in Example 3 was loaded into ANX-Sepharose chromatographic column (0.7 cm × 2.5 cm) for chromatographic separation, wherein, the flow rate was 0.1 mL/min, and the effluent was collected into tube at 0.2 mL/tube; the effluent in each tube was subjected to oligosaccharide detection and lactose detection, and the results were shown in
Figure 9 . - 2) 100 µL of nanofiltration retentate obtained in Example 3 was loaded into CM-Sepharose FF chromatographic column (0.7 cm × 2.5 cm) for chromatographic separation, wherein, the flow rate was 0.1 mL/min, and the effluent was collected into tube at 0.2 mL/tube; the effluent in each tube was subjected to oligosaccharide detection and lactose detection, and the results were shown in
Figure 10 . - 3) 100 µL of nanofiltration retentate obtained in Example 3 was loaded into QXL-Sepharose chromatographic column (0.7 cm × 2.5 cm) for chromatographic separation, wherein, the flow rate was 0.1 mL/min, and the effluent was collected into tube at 0.2 mL/tube; the effluent in each tube was subjected to oligosaccharide detection and lactose detection, and the results were shown in
Figure 11 . - 4) 100 µL of nanofiltration retentate obtained in Example 3 was loaded into SP-Sepharose FF chromatographic column (0.7 cm × 2.5 cm) for chromatographic separation, wherein, the flow rate was 0.1 mL/min, and the effluent was collected into tube at 0.2 mL/tube; the effluent in each tube was subjected to oligosaccharide detection and lactose detection, and the results were shown in
Figure 12 . - 5) 100 µL of nanofiltration retentate obtained in Example 3 was loaded into SP-Sepharose XL chromatographic column (0.7 cm × 2.5 cm) for chromatographic separation, wherein, the flow rate was 0.1 mL/min, and the effluent was collected into tube at 0.2 mL/tube; the effluent in each tube was subjected to oligosaccharide detection and lactose detection, and the results were shown in
Figure 13 . - As can be seen from
Figs. 9-13 , effective separation of sialyllactose from non-prebiotic substances cannot be achieved by applying the following five ion chromatographic packings: ANX-Sepharose chromatography, CM-Sepharose FF chromatography, QXL-Sepharose chromatography, SP-Sepharose FF chromatography, and SP-Sepharose XL chromatography. - The inventors of the present invention also attempted to perform other separation and purification procedures in the research and development process, as shown in Comparative examples 2 to 4 for details.
- The nanofiltration retentate in Example 3 was subjected to freeze-drying to obtain a crude milk oligosaccharide powder, 500 mg of the obtained powder and 3 g activated carbon were dissolved in 100 mL of different concentrations of ethanol solutions (5%, 10%, and 15%) to test the optimum concentration for BMO adsorption and lactose desorption. After stirring for 30 minutes, the mixture was filtered under vacuum through Whatman No. 1 filter paper and the activated carbon was washed with 25 mL of the corresponding ethanol solution. Milk oligosaccharides were desorbed from activated carbon with 100 mL ethanol solution (50%, v/v). The mixture was stirred for 30 min and filtered as described above. The filtrate was evaporated at 50 °C under vacuum and the solid was dissolved in 5 mL deionized water. Activated carbon used in this comparative example was purchased from Sigma Aldrich Company.
- Oligosaccharide detection and lactose detection were carried out, and the results were shown in
Figure 14 , which indicated that the adsorption by activated carbon in this comparative example cannot effectively remove lactose. - The nanofiltration retentate in Example 3 were loaded into dialysis bags with molecular weights of 100-500 Da and 500-1000 Da, respectively, for dialyzing with deionized water at 4 °C for 48 hours. The dialysis bags used in the comparative example were purchased from Shanghai Yuanye Co., Ltd.
- Oligosaccharide detection and lactose detection were carried out, and the results were shown in
Figure 15 , which indicated that the lactose removal rate by the dialysis bag with 100 to 500 Da in the comparative example was only about 81%, but the recovery rate of oligosaccharide from the retentate was not ideal; although the dialysis bag with 500 to 1000 Da can better remove lactose, the recovery rate of oligosaccharide was greatly reduced correspondingly. - The nanofiltration retentate in Example 3 was crystallized to produce lactose mother liquor. The nanofiltration retentate was concentrated to 50 °
B 6 by a rotary evaporator, and two fractions of the concentrate were added with 0.02% seed crystal for crystallization at room temperature and 4 °C, respectively, and the other two fractions were crystallized without addition of seed crystal under the same conditions as control. After obtaining the supernatant, the crystalline lactose was rinsed with a small amount of ice water (4 °C). Then, the crystallization conditions were screened based on the yield of oligosaccharide and the removal rate of lactose. The lactose seed crystal was purchased from Hilma (USA). - Oligosaccharide detection and lactose detection were carried out, and the results were shown in
Figure 16 , which indicated that the effect of removal of lactose by the crystallization method in this comparative example was not satisfying. - The results of the above Comparative examples 2 to 3 showed that, although a large amount of oligosaccharides can be recovered by activated carbon adsorption and crystallization method, a large amount of lactose were recovered correspondingly, and thereby the content of non-prebiotic substances was increased, which may affect the biological activity of milk oligosaccharides. Although the removal method by dialysis bag had a high removal rate of lactose, a lot of milk oligosaccharides were also reduced correspondingly. Therefore, these three methods cannot effectively separate sialyllactose from non-prebiotic substances (lactose), let alone meet the demand for industrialization.
- The chromatographic collections of 3'-sialyllactose and 6'-sialyllactose in Example 5 were combined (all of the three chromatographic packing materials in Example 5 can effectively separate milk oligosaccharides, and therefore, one or more chromatographic collections can be taken as an example; in this example, the collection from separation and purification by Q-Sepharose FF was used), and then subjected to nanofiltration for desalination, in which the used membrane unit was 100 Da.
- Alternatively, the above combined collection liquid was loaded into an electrodialysis device for desalination.
- The oligosaccharide detection method was the same as above, in which the above two reagents are used for derivatization and detection.
- Nanofiltration desalination: 1100 mL of the above combined collection liquid of Example 5 was loaded into a nanofiltration device with the inlet pressure of 10 bar and the outlet pressure of 5 bar. With the continuous penetration of the permeate, 9 L deionized water was added continuously, and when the conductivity no longer changed, the test was finished and the results were shown in
Figure 17 . - Electrodialysis desalination: 1700 mL of the above combined collection liquid of Example 5 was loaded into an electrodialysis device with 8 V of the adjustment voltage, 50 L/h of the material flow rate, 50 L/h of the ultra-pure water flow rate, and 45 L/h of the polar liquid flow rate, and when the electric current no longer changed, the test was finished, and the results were shown in
Figure 18 . - As can be seen from
Figs. 17 to 18 , the cumulative desalination rates of the nanofiltration desalination and the electrodialysis desalination were 96.61% and 94.5%, respectively, which indicated that these two methods had better desalination rates, and relatively speaking, the nanofiltration desalination showed higher efficiency without resulting in chemical pollution, thus being the preferred method. - The desalted milk oligosaccharide solution obtained in Example 6 was subjected to a freeze-drying procedure to obtain the milk oligosaccharide powder.
- Specifically, firstly, the solution was placed on the sample shelf of the freeze dryer for pre-freezing. Subsequently, according to the process, the heating program of vacuum freeze drying was set as: 20 °C for 2 h, 40 °C for 1 h, and 55 °C until to the end. Additionally, the cold trap temperature was set at -50 °C, and the vacuum degree was at 2.50 to 6.50 MPa. The drying was not finished until the moisture content on dry basis was less than 5%. The physical image of the bovine milk whey powder was shown in
Fig. 19 . As can be seen fromFig. 19 , the bovine milk oligosaccharide powder was white or light yellow in color, uniform in size, and there were no impurities visible. - The preparation method of the present disclosure comprises the following steps: skimmed milk being subjected to microfiltration concentration to obtain a microfiltration permeate, the microfiltration permeate being then subjected to ultrafiltration to obtain an ultrafiltration permeate (or the reconstituted desalted whey powder solution being subjected to ultrafiltration to obtain the ultrafiltration permeate), the ultrafiltration permeate being then subjected to nanofiltration to obtain a nanofiltration retentate, the nanofiltration permeate being then subjected to reverse osmosis to prepare reverse osmosis water, which is then used in the washing and filtering steps of microfiltration, ultrafiltration, and nanofiltration, thereby forming a series of environment-friendly processes, removing the residual lactose from the nanofiltration retentate by chromatography, subjecting the chromatographic collection liquid to another nanofiltration to obtain the milk oligosaccharide solution, which is then subjected to freeze-drying to obtain the milk oligosaccharide powder. In the present disclosure, the milk oligosaccharide powder is obtained by microfiltration, ultrafiltration, nanofiltration, reverse osmosis, chromatography, and freeze-drying technologies, which do not involve fermentation and enzymatic conversion as compared with that produced by the traditional bioengineering technology, and thereby remain the natural structure of milk oligosaccharides. Additionally, it has excellent processing quality characteristics and pure flavor, and shows wide application prospects in food industry.
- Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention and not to limit it; although the present invention has been described in detail with reference to the foregoing embodiments, it will be understood by one of ordinary skill in the art that the technical solutions described in the foregoing embodiments can still be modified or some technical features can be equivalently substituted; however, these modifications or substitutions do not make the essence of the corresponding technical solutions departing from the spirit and scope of the technical solutions of various embodiments of the present invention.
- The present disclosure provides a method for preparing milk oligosaccharides, and milk oligosaccharide powder and food prepared by the same, wherein the method comprises the following steps of: performing ultrafiltration of whey liquid for at least three times, subjecting the ultrafiltration permeate to nanofiltration concentration for several times, then subjecting the nanofiltration retentate to chromatographic separation and purification, collecting chromatographic collection liquid containing sialyllactose while removing the fraction containing lactose, subjecting the collection to desalination and drying to obtain the oligosaccharide powder. The milk oligosaccharides prepared by the present invention and the food products containing the same comprise basically bovine milk oligosaccharides, which are light yellow or white in color, light in flavor, uniform in size, and have good thermal stability and solubility. The milk oligosaccharides mainly comprise 3'-sialyllactose and 6'-sialyllactose.
Claims (10)
- A method for preparing milk oligosaccharides, comprising the steps of: performing ultrafiltration of whey liquid for at least three times, subjecting the ultrafiltration permeate to nanofiltration concentration for several times, then subjecting the nanofiltration retentate to chromatographic separation and purification, collecting chromatographic collection liquid containing sialyllactose while removing the fraction containing lactose, subjecting the collection to desalination and drying to obtain oligosaccharide powder.
- The method according to Claim 1, wherein said collecting chromatographic collection liquid containing sialyllactose is performed as follows: collecting the chromatographic collection liquid into a tube and performing detections on the same, and combining the chromatographic collection liquid containing sialyllactose, in which the detection of sialyllactose is performed by the oligosaccharide detection method;and/or, the drying step is performed by freeze drying; optionally, the freeze-drying step comprises: loading the desalted concentrated retentate into a freeze dryer for drying, further optionally, the freeze-drying step comprises: setting the heating program of the vacuum freeze-drying as: 20°C for 2 h, 40°C for 1 h, and 55°C until to the end, with the cold trap temperature being set at -50 °C,and the vacuum degree at 2.50 to 6.50 MPa, and the drying is not finished until the moisture content on dry basis is less than 5%.
- The method according to Claim 1, wherein, in the chromatographic separation and purification step, the chromatographic packing material uses a cross-linked complex of agarose and dextran or a cross-linked agarose as the carrier; optionally, the carrier of the chromatographic packing material is Superdex 30 increase pre-loaded column, or DEAE-Sepharose Fast Flow, or Q-Sepharose Fast Flow; optionally, the chromatographic separation and purification step comprises:loading the nanofiltration retentate into Superdex 30 increase pre-loaded column at a flow rate of 0.5 to 0.8 mL/min, and collecting the effluent at 0.5 to 2 mL/tube; optionally, the flow rate is 0.6 mL/min, and the collection of the effluent is performed at 1 mL/tube;or, loading the nanofiltration retentate into a 1.5 cm × 20 cm DEAE-Sepharose FF column at a flow rate of 1 to 2 mL/min, and collecting the effluent at 0.5-1.5 mL/tube; optionally, the flow rate is 1.5 mL/min, and the collection of the effluent is performed at 1 mL/tube;or, loading the nanofiltration retentate into a 10 cm × 50 cm Q-Sepharose FF column at a flow rate of 15 to 25 mL/min, and collecting the effluent at 40 to 60 mL/tube; optionally, the flow rate is 20 mL/min, and the collection of the effluent is performed at 50 mL/tube.
- The method according to Claim 1, wherein the whey liquid is a by-product whey liquid produced during cheese manufacturing, or a whey liquid after the desalted whey powder is reconstituted, or a permeate prepared by microfiltration of skimmed animal milk, in which, optionally, the animal milk is bovine milk; and optionally, the mass ratio of desalted whey powder to water is 1: 4 to 20;optionally, the method of preparing the permeate from the animal milk by microfiltration comprises: subjecting the skimmed animal milk to microfiltration for at least three times to obtain the microfiltration permeate; optionally, the percentage content of fat in the skimmed animal milk is less than or equal to 0.1% by mass, preferably is 0.02% to 0.1% by mass;optionally, the animal milk skimming step comprises: sterilizing the raw milk and then cooling to 45 to 55°C through a plate heat exchanger for skimming;optionally, the microfiltration for at least three times comprises: concentrating the skimmed animal milk through microfiltration until reaching 2 to 5 cycles of concentration to obtain the first microfiltration permeate; diluting the first microfiltration retentate with water, followed by concentrating through microfiltration until reaching 2 to 5 cycles of concentration to obtain the second microfiltration permeate; diluting the second microfiltration retentate with water, followed by concentrating through microfiltration until reaching 2 to 5 cycles of concentration to obtain the third microfiltration permeate, and so on; optionally, the microfiltration is performed five times; optionally, dilution with water is carried out until the quality is similar to that of the skimmed animal milk before microfiltration;optionally, in the concentration through microfiltration, the used microfiltration membrane has a pore diameter of 50 nm-140 nm; optionally, the microfiltration membrane adopts a tubular ceramic membrane;optionally, the microfiltration is performed under conditions as follows: the feed temperature is 45 °C to 55 °C, the inlet pressure is 2 to 5 bar, the outlet pressure is 1 to 4 bar, the back pressure is 0.5 to 3 bar, and the membrane pressure difference is less than 3 bar.
- The method according to Claim 1, wherein the ultrafiltration for at least three times comprises: concentrating the microfiltration permeate through ultrafiltration until reaching 2 to 7 cycles of concentration to obtain the first ultrafiltration permeate; diluting the first ultrafiltration retentate with water, followed by concentrating through ultrafiltration until reaching 2 to 7 cycles of concentration to obtain the second ultrafiltration permeate; diluting the second ultrafiltration retentate with water, followed by concentrating through ultrafiltration until reaching 2 to 7 cycles of concentration to obtain the third ultrafiltration permeate, and so on; optionally, the ultrafiltration is performed six times; optionally, the amount of water added for dilution is similar to the mass of ultrafiltration retentate to be diluted;and/or, in the ultrafiltration step, the used ultrafiltration membrane has a molecular weight cut-off of 5 kDa to 30 kDa; optionally, the ultrafiltration membrane is a composite tubular organic membrane;and/or, the ultrafiltration is performed under conditions as follows: the feed temperature is 20 °C to 45 °C, the inlet pressure is 6 to 9 bar, the outlet pressure is 5 to 8 bar; optionally, the membrane pressure difference is not more than 3 bar.
- The method according to Claim 1, wherein the procedure of nanofiltration concentration for several times comprises: concentrating the ultrafiltration permeate through nanofiltration until reaching 2 to 13 cycles of concentration to obtain the first nanofiltration retentate; diluting the first nanofiltration retentate with water, followed by concentrating through nanofiltration until reaching 2 to 13 cycles of concentration to obtain the second nanofiltration retentate; diluting the second nanofiltration retentate with water, followed by concentrating through nanofiltration until reaching 2 to 13 cycles of concentration to obtain the third nanofiltration retentate, and so on; alternatively, the nanofiltration is performed six times; optionally, the amount of water added for dilution is similar to that of nanofiltration retentate to be diluted;and/or, in the nanofiltration step, the used nanofiltration membrane has a molecular weight cut-off of 100 Da to 3000 Da; optionally, the nanofiltration membrane used in the nanofiltration step is a composite tubular organic membrane;and/or, the nanofiltration is performed under conditions as follows: the feed temperature is 20 °C to 45 °C, the inlet pressure is 16 to 20 bar, the outlet pressure is 14 to 18 bar; optionally, the membrane pressure difference is not more than 3 bar.
- The method according to Claim 1, wherein the desalination is performed by nanofiltration or electrodialysis;optionally, the desalination by nanofiltration comprises: separating the chromatographic collection liquid through nanofiltration, washing and filtering with deionized water until the conductivity does not decrease any longer, and concentrating to the minimum cycling volume of the device to obtain a concentrated nanofiltration retentate, at which time the nanofiltration concentration is finished; optionally, the nanofiltration membrane used in the desalination by nanofiltration has a molecular weight cut-off of 100 Da to 500 Da; optionally, the nanofiltration membrane used in the desalination by nanofiltration is a composite tubular organic membrane; optionally, the desalination by nanofiltration is performed under conditions as follows: the feed temperature is 20 °C to 45 °C, the inlet pressure is 10 to 15 bar, and the outlet pressure is 5 to 10 bar; optionally, the membrane pressure difference is not more than 3 bar;optionally, the procedure of electrodialysis comprises: loading the chromatographic collection liquid into an electrodialysis device for dialysis until the electric current does not change any longer, at which time the desalination is finished; optionally, the electrodialysis is performed under conditions as follows: regulation voltage: 8 V, feed flow rate: 50 L/h, ultra-pure water flow rate: 50 L/h, polar liquid flow rate: 45 L/h.
- The method according to Claim 1, wherein the method further comprises: concentrating the nanofiltration permeate by reverse osmosis to generate deionized water suitable for the process; optionally, the concentration by reverse osmosis specifically comprises: concentrating the nanofiltration permeate by reverse osmosis to the minimum cycling volume of the device to obtain a reverse osmosis permeate, at which time the reverse osmosis is finished;optionally, the membrane used in the reverse osmosis has a stable desalination rate of 99.5%; optionally, the reverse osmosis is performed under conditions as follows: the feed temperature is 20 °C to 45 °C, the inlet pressure is 16 to 20 bar, the outlet pressure is 14 to 18 bar; optionally, the membrane pressure difference is not more than 3 bar;and/or, the procedures of ultrafiltration, nanofiltration, and reverse osmosis adopt an integrated ultrafiltration-nanofiltration-reverse osmosis device.
- An oligosaccharide powder, which is a milk oligosaccharide powder prepared by the method according to any of Claims 1 to 8; optionally, the milk oligosaccharide powder comprises sialyllactose; optionally, the sialyllactose comprises 3'-sialyllactose and 6'-sialyllactose; optionally, the total percentage content of 3'-sialyllactose and 6'-sialyllactose in the milk oligosaccharide powder is not less than 25% by mass, optionally, the total percentage content of 3'-sialyllactose and 6'-sialyllactose in the milk oligosaccharide powder is not less than 50% by mass.
- An oligosaccharide food or health product, comprising the oligosaccharide powder prepared by the method according to any of Claims 1 to 8 or the oligosaccharide powder according to Claim 9.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111649065.5A CN114539433B (en) | 2021-12-29 | 2021-12-29 | Preparation method of lacto-oligosaccharide, and oligosaccharide powder and food prepared by same |
PCT/CN2022/135023 WO2023124706A1 (en) | 2021-12-29 | 2022-11-29 | Method for preparing milk oligosaccharide, oligosaccharide powder prepared using same, and food |
Publications (2)
Publication Number | Publication Date |
---|---|
EP4230050A1 true EP4230050A1 (en) | 2023-08-23 |
EP4230050A4 EP4230050A4 (en) | 2024-06-12 |
Family
ID=86898323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP22859565.8A Pending EP4230050A4 (en) | 2021-12-29 | 2022-11-29 | Method for preparing milk oligosaccharide, oligosaccharide powder prepared using same, and food |
Country Status (4)
Country | Link |
---|---|
US (1) | US20230203206A1 (en) |
EP (1) | EP4230050A4 (en) |
JP (1) | JP7564349B2 (en) |
AU (1) | AU2022331912B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118047820B (en) * | 2024-04-16 | 2024-07-19 | 北京三元食品股份有限公司 | Preparation method of 3-fucosyllactose and prepared standard substance |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES1056525Y (en) * | 2004-01-13 | 2004-07-16 | Perez Alfredo Pineiro | THREE ROLLER FINDER FOR NETWORKS AND FISHING APPARATUSES. |
FR2907687B1 (en) * | 2006-10-30 | 2008-12-26 | Applexion | PROCESS FOR PURIFYING SIALYLLACTOSE BY CHROMATOGRAPHY |
JPWO2009008362A1 (en) * | 2007-07-12 | 2010-09-09 | よつ葉乳業株式会社 | Method for producing sialic acid compound-containing composition |
NL2001377C2 (en) * | 2008-03-14 | 2009-09-15 | Friesland Brands Bv | Process for isolating sialic acid-containing oligosaccharides, as well as the compositions containing sialic acid-containing oligosaccharides. |
GB0904562D0 (en) * | 2009-03-17 | 2009-04-29 | Separation Technologies Invest | Isolation and purification of components of whey |
JP5599994B2 (en) * | 2009-09-29 | 2014-10-01 | 雪印メグミルク株式会社 | Separation method of sialyl lactose material |
EP2885977A1 (en) * | 2013-12-19 | 2015-06-24 | Agriculture and Food Development Authority (TEAGASC) | An oligosaccharide-enriched composition having immune-modulatory and anti-adhesion properties |
JP7143286B2 (en) | 2016-09-19 | 2022-09-28 | プロラクタ バイオサイエンス,インコーポレイテッド | Purified human milk oligosaccharide composition |
EP3494807A1 (en) * | 2017-12-11 | 2019-06-12 | Jennewein Biotechnologie GmbH | Spray-dried sialyllactose |
WO2019229118A1 (en) * | 2018-06-01 | 2019-12-05 | Jennewein Biotechnologie Gmbh | A simple method for the purification of a sialyllactose |
CN109744316A (en) | 2019-01-22 | 2019-05-14 | 浙江工业大学 | A kind of demulsification sugar-milk preparation method based on separation membrane technology |
-
2022
- 2022-11-29 JP JP2023517673A patent/JP7564349B2/en active Active
- 2022-11-29 AU AU2022331912A patent/AU2022331912B2/en active Active
- 2022-11-29 EP EP22859565.8A patent/EP4230050A4/en active Pending
-
2023
- 2023-03-01 US US18/176,611 patent/US20230203206A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP4230050A4 (en) | 2024-06-12 |
US20230203206A1 (en) | 2023-06-29 |
AU2022331912B2 (en) | 2024-05-02 |
JP2023554574A (en) | 2023-12-28 |
JP7564349B2 (en) | 2024-10-08 |
AU2022331912A1 (en) | 2023-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2023124706A1 (en) | Method for preparing milk oligosaccharide, oligosaccharide powder prepared using same, and food | |
JP2021505173A (en) | Spray-dried mixture of human milk oligosaccharides | |
JP2021503898A (en) | Method for Purifying L-Fucose from Fermented Broth | |
Zhang et al. | Leaf protein concentration of alfalfa juice by membrane technology | |
CN111094311A (en) | Method for purifying sialylated oligosaccharides | |
EP3741770A1 (en) | Purification of oligosaccharides from a fermentation broth by using filtration | |
RU2555522C1 (en) | Complex milk salt, its production method and food products containing such salt | |
US20230203206A1 (en) | Preparation method of milk oligosaccharides and oligosaccharide powder and food prepared thereby | |
CN107325205A (en) | A kind of inulin and FOS syrup co-production | |
EP3686210A1 (en) | Process for purifying a human milk oligosaccharide and related compositions | |
CN111978423B (en) | Preparation method of high-purity galactooligosaccharide | |
JP2022514350A (en) | A method for separating biomass from a solution containing biomass and at least one oligosaccharide. | |
US20230227487A1 (en) | Improved demineralization of fermentation broths and purification of fine chemicals such as oligosaccharides | |
CN106994130A (en) | High-purity galactooligosacchari(es composition and preparation method thereof and purposes | |
Ayed et al. | Sustainable whey processing techniques: Innovations in derivative and beverage production | |
CN109517857A (en) | A kind of method of fermentation and extraction purifying L-Leu | |
CN105124689A (en) | Processing method and application of carmine red radish condensed juice products | |
CN104694614B (en) | A kind of extraction process of L-Trp | |
CN115176845A (en) | Fermentation preparation process of phycocyanin coconut-flavor sucrose-free yoghurt powder | |
CN116784468A (en) | Sweet composition and preparation method and application thereof | |
CN106748848A (en) | A kind of technique for preparing branched-chain amino acid and its application | |
CN117481198B (en) | Membrane separation recombination method for core nutritional ingredients of infant milk product and application of membrane separation recombination method | |
CN108264528A (en) | A kind of method that lactose is isolated and purified from whey | |
RU2810298C2 (en) | Spray dried 3-fucosyllactose | |
CN105533381A (en) | High nutrition pure solid saccharum officinarum juice and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20230303 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40100681 Country of ref document: HK |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20240515 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: B01D 15/36 20060101ALI20240508BHEP Ipc: B01D 15/34 20060101ALI20240508BHEP Ipc: B01D 15/24 20060101ALI20240508BHEP Ipc: C07H 1/08 20060101ALI20240508BHEP Ipc: C08B 37/00 20060101ALI20240508BHEP Ipc: B01D 15/20 20060101ALI20240508BHEP Ipc: A23L 33/00 20160101ALI20240508BHEP Ipc: A23L 3/44 20060101ALI20240508BHEP Ipc: A61K 31/702 20060101ALI20240508BHEP Ipc: A23C 9/146 20060101ALI20240508BHEP Ipc: C07H 3/06 20060101ALI20240508BHEP Ipc: C07H 1/06 20060101ALI20240508BHEP Ipc: B01D 15/08 20060101ALI20240508BHEP Ipc: B01D 61/42 20060101ALI20240508BHEP Ipc: B01D 61/14 20060101ALI20240508BHEP Ipc: B01D 61/02 20060101ALI20240508BHEP Ipc: B01D 61/58 20060101ALI20240508BHEP Ipc: A23L 33/125 20160101ALI20240508BHEP Ipc: G01N 30/02 20060101ALI20240508BHEP Ipc: A23C 9/144 20060101ALI20240508BHEP Ipc: A23C 9/142 20060101AFI20240508BHEP |